Physiopathological Treatment Approach and Position of Pioglitazone in Type 2 Diabetes

Authors:
  • AŞAbdulhalim Şenyiğit
    Abdulhalim Şenyiğit
  • MKMustafa Kanat
    Mustafa Kanat

Abstract
No abstract available